Skip to main content
. 2020 Jun 30;11(26):2560–2570. doi: 10.18632/oncotarget.27652

Table 3. Causes of TKI discontinuation according to transcript type (e13a2 versus e14a2) (n = 39).

Causes of TKI discontinuation N = (%)
e14a2 e13a2 p =
Failure 7 (30.4) 4 (25)
Side-effect 6 (26.1) 8 (50)
TFR-attempt 10 (43.5) 3 (18.8)
Other 0 (0) 1 (6.2)
Total 23 (100) 16 (100) .19

Abbreviations: TFR, treatment-free remission; TKI, tyrosine kinase inhibitor. Results were compared using Fischer’s exact method.